SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter earnings of $217.1 million.
On a per-share basis, the Silver Spring, Maryland-based company said it had profit of $4.36.
The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.92 per share.
The drugmaker posted revenue of $614.7 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $561.8 million.
For the year, the company reported profit of $984.8 million, or $19.81 per share. Revenue was reported as $2.33 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR